• Provide manufacturers with a complete service: technical and scientific feasibility study, usage study, clinical study, medico-economic analysis, market study and development of the minimum viable product.
• To become a central axis of inclusive and participatory innovation, by proposing a structuring of the entire research and development continuum of a product or service.

The MTL-TLE consortium proposes a unique offering in Francethat combines living lab methodologies, particularly design thinking, with engineering sciences, medical sciences, and the humanities and social sciences. Its main objective is to experiment and test new technologies and medical practices directly in the field.This is done through the active participation of users, healthcare professionals and researchers, enabling medical devices and services to be adapted to the real needs of each patient.

The MTL-TLE also aims to become a center for the training and dissemination of medical innovations, addressing the issue of technology adoption. By involving patients and healthcare professionals right from the device design stage, these spaces promote the rapid appropriation of innovations and limit the risk of failure by guaranteeing user buy-in.
To ensure the effectiveness of these initiatives, thee MTL-TLE adopts an ethical and responsible approach, respecting in particular the confidentiality of patient data and taking care not to expose them to unnecessary risks.
The MTL-TLE is a member of the Forum des Living Labs en Santé et Autonomie (LLSA Forum) and the ENoLL (European Network of Living Labs), thus participating in a national and international network in the health and autonomy sector.